Dr. Angela Winegar

Senior Director of Health Economics & Clinical Effectiveness Ascension

Dr. Angela Winegar serves as the Senior Director of Health Economics and Clinical Effectiveness within the Ascension Data Sciences Institute, an organization that supports Ascension’s 151 hospitals and approximately 34,000 employed and affiliated healthcare providers. Her team, which consists of analysts and data scientists, applies machine learning techniques to decrease unwarranted clinical variation and deliver more reliable, cost-effective care. To prepare Ascension for the expected move to value-based reimbursement models, Dr. Winegar leads efforts to develop balanced service-line reports. These track acute-care and ambulatory quality, financial data, growth, and operational efficiency performance; they are risk adjusted to account for heterogeneity within the patient population. Additionally, she partners with clinician leaders to conduct large-scale, real-world clinical effectiveness studies, made possible by pulling in data from Ascension’s standard cost accounting system, clinical registries and soon, claims data. Dr.

Winegar has more than 15 years of experience supporting the healthcare industry, including pharmaceutical, biotechnology and medical device manufacturers, as well as large provider organizations. Her success in engaging and communicating with physicians to translate analytic output into meaningful care improvement opportunities has resulted in several peer-reviewed publications. Dr. Winegar earned her undergraduate degree in molecular biology from Princeton University and her doctoral degree in health economics and outcomes from the University of Texas College of Pharmacy in Austin. She serves as affiliate faculty for the department of surgery and perioperative care at the Dell Medical School at the University of Texas at Austin.


Agenda Day 1: Sunday, November 17, 2019

4:50 PM Creating Organizational Alignment by Leveraging Clinical Analytics to Improve Care Effectiveness

The integration of advanced analytics and reporting measures into clinical workflows necessitates close collaboration between data science leaders and clinicians. As value-based care and other alternative payment models continue to reshape traditional care delivery models, it’s becoming increasingly critical that organizations implement a proactive approach to deploy predicative analytic and other advanced technologies into clinical environments. Angela Winegar, Senior Director, Health Economics and Clinical Effectiveness at the Ascension Data Sciences Institute, will lead this session exploring her approach to developing a results-driven approach to building consensus among clinical, financial, and administrative leaders through translational analytics.

Participate in this session to gain insights into:
•The importance of creating real-world, holistic models that accurately measure clinical effectiveness 
•Creating a framework to track costs savings generated from optimized clinical processes and reductions in clinical variation
•Developing and accessing strategies to harness clinical analytics to improve performance under alternative payment models

Agenda Day 2: Monday, November 18, 2019

12:00 PM Energizing Data Scientists to Embrace Working in Healthcare

The healthcare profession is responsible for saving countless lives every day and touches the lives of every single American in some form or the other. Yet, many CDAO’s are struggling to attract and retain talent compared to well-know, tech savvy brands. Participate in this panel to engage in an honest discussion centered on how some of your peers are improving their talent pipelines and communicating the value of joining the healthcare industry for data scientists.